367 related articles for article (PubMed ID: 10500495)
21. Synthesis and evaluation of DNA-targeted spatially separated bis(aniline mustards) as potential alkylating agents with enhanced DNA cross-linking capability.
Gourdie TA; Prakash AS; Wakelin LP; Woodgate PD; Denny WA
J Med Chem; 1991 Jan; 34(1):240-8. PubMed ID: 1992124
[TBL] [Abstract][Full Text] [Related]
22. Polybenzamide mustards: structure-activity relationships for DNA sequence-specific alkylation.
Turner PR; Ferguson LR; Denny WA
Anticancer Drug Des; 1999 Feb; 14(1):61-70. PubMed ID: 10363028
[TBL] [Abstract][Full Text] [Related]
23. Aniline mustard analogues of the DNA-intercalating agent amsacrine: DNA interaction and biological activity.
Fan JY; Valu KK; Woodgate PD; Baguley BC; Denny WA
Anticancer Drug Des; 1997 Apr; 12(3):181-203. PubMed ID: 9154110
[TBL] [Abstract][Full Text] [Related]
24. DNA interstrand cross-linking, DNA sequence specificity, and induced conformational changes produced by a dimeric analog of (+)-CC-1065.
Ding ZM; Hurley LH
Anticancer Drug Des; 1991 Nov; 6(5):427-52. PubMed ID: 1662513
[TBL] [Abstract][Full Text] [Related]
25. DNA alkylation and interstrand cross-linking by treosulfan.
Hartley JA; O'Hare CC; Baumgart J
Br J Cancer; 1999 Jan; 79(2):264-6. PubMed ID: 9888467
[TBL] [Abstract][Full Text] [Related]
26. Synthesis, DNA binding, cytotoxicity and sequence specificity of a series of imidazole-containing analogs of the benzoic acid mustard distamycin derivative tallimustine containing an alkylating group at the C-terminus.
Brooks N; Lee M; Wright SR; Woo S; Centioni S; Hartley JA
Anticancer Drug Des; 1997 Oct; 12(7):591-606. PubMed ID: 9365504
[TBL] [Abstract][Full Text] [Related]
27. Highly efficient sequence-specific DNA interstrand cross-linking by pyrrole/imidazole CPI conjugates.
Bando T; Narita A; Saito I; Sugiyama H
J Am Chem Soc; 2003 Mar; 125(12):3471-85. PubMed ID: 12643709
[TBL] [Abstract][Full Text] [Related]
28. Identification of the major lesion from the reaction of an acridine-targeted aniline mustard with DNA as an adenine N1 adduct.
Boritzki TJ; Palmer BD; Coddington JM; Denny WA
Chem Res Toxicol; 1994; 7(1):41-6. PubMed ID: 8155823
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis, DNA sequence preferential alkylation and biological evaluation of N-mustard derivatives of distamycin and netropsin analogues.
Xie G; Gupta R; Lown JW
Anticancer Drug Des; 1995 Jul; 10(5):389-409. PubMed ID: 7639929
[TBL] [Abstract][Full Text] [Related]
30. Construction of a human shuttle vector containing a single nitrogen mustard interstrand, DNA-DNA cross-link at a unique plasmid location.
Grueneberg DA; Ojwang JO; Benasutti M; Hartman S; Loechler EL
Cancer Res; 1991 May; 51(9):2268-72. PubMed ID: 2015591
[TBL] [Abstract][Full Text] [Related]
31. Alkylation specificity for a series of distamycin analogues that tether chlorambucil.
Wyatt MD; Lee M; Hartley JA
Anticancer Drug Des; 1997 Jan; 12(1):49-60. PubMed ID: 9051113
[TBL] [Abstract][Full Text] [Related]
32. Effect of nitroreduction on the alkylating reactivity and cytotoxicity of the 2,4-dinitrobenzamide-5-aziridine CB 1954 and the corresponding nitrogen mustard SN 23862: distinct mechanisms of bioreductive activation.
Helsby NA; Wheeler SJ; Pruijn FB; Palmer BD; Yang S; Denny WA; Wilson WR
Chem Res Toxicol; 2003 Apr; 16(4):469-78. PubMed ID: 12703963
[TBL] [Abstract][Full Text] [Related]
33. RecA-catalyzed, sequence-specific alkylation of DNA by cross-linking oligonucleotides. Effects of length and nonhomologous base substitutions.
Podyminogin MA; Meyer RB; Gamper HB
Biochemistry; 1996 Jun; 35(22):7267-74. PubMed ID: 8679556
[TBL] [Abstract][Full Text] [Related]
34. Efficient guanine alkylation through cooperative heterodimeric formation of duocarmycin A and distamycin A.
Isomura M; Sugiyama H; Saito I
Nucleic Acids Symp Ser; 1995; (34):47-8. PubMed ID: 8841545
[TBL] [Abstract][Full Text] [Related]
35. Design, synthesis, DNA sequence preferential alkylation and biological evaluation of N-mustard derivatives of Hoechst 33258 analogues.
Gupta R; Wang H; Huang L; Lown JW
Anticancer Drug Des; 1995 Jan; 10(1):25-41. PubMed ID: 7535056
[TBL] [Abstract][Full Text] [Related]
36. Synthesis, DNA binding and cytotoxicity of 1-[[omega-(9-acridinyl)amino]alkyl]carbonyl -3-(chloromethyl)-6-hydroxyindolines, a new class of DNA-targeted alkylating agents.
Fan JY; Tercel M; Denny WA
Anticancer Drug Des; 1997 Jun; 12(4):277-93. PubMed ID: 9199660
[TBL] [Abstract][Full Text] [Related]
37. The effects of a benzoic acid mustard derivative of distamycin A (FCE 24517) and related minor groove-binding distamycin analogues on the activity of major groove-binding alkylating agents.
Coley HM; Mongelli N; D'Incalci M
Biochem Pharmacol; 1993 Feb; 45(3):619-26. PubMed ID: 8442762
[TBL] [Abstract][Full Text] [Related]
38. Anomalous cross-linking by mechlorethamine of DNA duplexes containing C-C mismatch pairs.
Romero RM; Mitas M; Haworth IS
Biochemistry; 1999 Mar; 38(12):3641-8. PubMed ID: 10090751
[TBL] [Abstract][Full Text] [Related]
39. Cross-linking and sequence specific alkylation of DNA by aziridinyl quinones. 2. Structure requirements for sequence selectivity.
Hargreaves RH; Mayalarp SP; Butler J; McAdam SR; O'Hare CC; Hartley JA
J Med Chem; 1997 Jan; 40(3):357-61. PubMed ID: 9022802
[TBL] [Abstract][Full Text] [Related]
40. Mono- and dysfunctional nitrogen mustard analogues of the DNA minor groove binder pibenzimol. Synthesis, cytotoxicity and interaction with DNA.
Smaill JB; Fan JY; Papa PV; O'Connor CJ; Denny WA
Anticancer Drug Des; 1998 Apr; 13(3):221-42. PubMed ID: 9595035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]